financetom
Business
financetom
/
Business
/
Correction: Karnalyte Resources Posts Steady Q1 Loss, Restates 2024 Results
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Correction: Karnalyte Resources Posts Steady Q1 Loss, Restates 2024 Results
May 26, 2025 9:39 AM

11:59 AM EDT, 05/16/2025 (MT Newswires) -- (Corrects to second paragraph to show a loss of $564,00 in the quarter, not $564 million.)

Karnalyte Resources ( KRLTF ) late on Thursday reported that its first-quarter loss held relatively steady and that it restated its full-year 2024 financial statements.

For the quarter, the net and comprehensive loss increased to $564,000, or $0.01 per share, compared with $522,000, or $0.01, in the year-prior quarter.

The company restated its 2024 financial statements to increase the decommissioning liability amount from $1.3 million to $1.6 million. The decommissioning liability reports the discounted amount of estimated costs required to settle Karnalyte's obligations to dismantle, decommission and complete activities to remediate site disturbance, which are expected to be incurred in 2038.

The company does not expect any adverse effect on day-to-day operations as a result of the restatement.

Karnalyte shares were last seen up $0.015 to $0.16 on the Toronto Stock Exchange.

Price: 0.16, Change: +0.02, Percent Change: +10.34

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Apple set to sell Vision Pro headset outside US, Bloomberg News reports
Apple set to sell Vision Pro headset outside US, Bloomberg News reports
May 13, 2024
May 13 (Reuters) - Apple ( AAPL ) is gearing up to sell its Vision Pro mixed-reality headset outside the United States, Bloomberg News reported on Monday, in a bid to invigorate demand for its most expensive bet in years. The iPhone-maker has flown hundreds of employees from its international stores to Cupertino, California and started training them on how...
Update: Novo Nordisk Reportedly Asked by US Senator to Reduce Prices of Ozempic, Wegovy Drugs in US
Update: Novo Nordisk Reportedly Asked by US Senator to Reduce Prices of Ozempic, Wegovy Drugs in US
May 13, 2024
12:56 PM EDT, 05/13/2024 (MT Newswires) -- (Updates with Novo Nordisk ( NVO ) response in the fourth and fifth paragraphs, and stock movement in the final paragraph.) Novo Nordisk ( NVO ) , based in Denmark, has been asked by Bernie Sanders of Vermont to reduce the prices of its Ozempic and Wegovy drugs in the US, multiple media...
Jasper Therapeutics to Expand Mast Cell Portfolio, Initiates Asthma Study in Q4
Jasper Therapeutics to Expand Mast Cell Portfolio, Initiates Asthma Study in Q4
May 13, 2024
12:59 PM EDT, 05/13/2024 (MT Newswires) -- Jasper Therapeutics ( JSPR ) said Monday it is expanding the company's mast cell development portfolio and will evaluate briquilimab, a conditioning agent for patients undergoing stem cell transplant, in patients with asthma in phase 1b/2a study. Enrolling in the study is expected to start in Q4, according to the company. We plan...
Home Depot 'Well Positioned' Amid Macroeconomic Uncertainty, BofA Says
Home Depot 'Well Positioned' Amid Macroeconomic Uncertainty, BofA Says
May 13, 2024
12:53 PM EDT, 05/13/2024 (MT Newswires) -- Home Depot ( HD ) is well-positioned to gain market share amid choppy macroeconomic conditions, BofA Securities said in a note. While the macro remains choppy, and we expect continued pressure in 2024 on discretionary and big ticket, we expect HD to see continued share gains as it accelerates growth and capabilities with...
Copyright 2023-2026 - www.financetom.com All Rights Reserved